BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10867870)

  • 1. [The effect of medikhronal on the psychophysiological and metabolic processes in alcoholism].
    Kharchenko NK; Duplenko PIu; Kovtun TV; Stohniĭ NA; Synyts'kyĭ VM
    Fiziol Zh (1994); 2000; 46(2):116-23. PubMed ID: 10867870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The new anti-alcohol preparation medikhronal: changes in the level of ethanol, acetaldehyde and monoamines during the treatment of alcoholism patients].
    Bozhko GKh; Voloshin PV; Boĭko TP; Kostiukovskaia LS; Kholodnyĭ IuG; Markozova LM; Bolotova ZN
    Eksp Klin Farmakol; 1994; 57(4):64-6. PubMed ID: 7950793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The action of medikhronal (glucose-glycine-formate) on catecholamine excretion in alcoholics].
    Bozhko GKh; Voloshin PV; Boĭko TP; Markozova LM; Bolotova ZN
    Eksp Klin Farmakol; 1994; 57(3):22-4. PubMed ID: 8049621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of medikhronal on the biogenic amine level in the brain structures and blood of animals with alcohol dependence].
    Kharchenko NK
    Fiziol Zh (1994); 1999; 45(4):111-9. PubMed ID: 10474811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of acetaldehyde in the pathogenetic mechanisms of the development of chronic alcoholism].
    Sinitskiĭ VN; Kharchenko NK
    Fiziol Zh (1994); 1994; 40(3-4):94-100. PubMed ID: 7621963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The action of medichronal (glucose-glycine-formate) on the serotonin blood level in alcoholism patients].
    Bozhko GKh; Voloshin PV; Kostiukovskaia LS; Markozova LM; Bolotova ZN
    Lik Sprava; 1995; (5-6):130-2. PubMed ID: 8630781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The characteristics of the metabolic and psychophysiological disorders in patients in different stages of chronic alcoholism].
    Kharchenko NK
    Fiziol Zh (1994); 1999; 45(3):79-86. PubMed ID: 10439295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A combined treatment method for alcoholic patients using medikhronal, microwave resonance therapy and holotropic breathing].
    Zaritskiĭ MG
    Lik Sprava; 1998; (7):126-32. PubMed ID: 10050481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medichronal lowers blood ethanol and acetaldehyde and restores the concentration of catecholamines in rat tissues].
    Bozhko HKZh ; Boĭko TP; Kostiukovs'ka LS
    Ukr Biokhim Zh (1978); 1995; 67(2):108-12. PubMed ID: 8592777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in lipid metabolism with the use of alcohol deterrent preparations].
    Selevich MI; Lelevich VV
    Eksp Klin Farmakol; 1999; 62(1):70-4. PubMed ID: 10198774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of alcoholism with metadoxil].
    Iakovlev VA
    Voen Med Zh; 1999 Oct; 320(10):57-9. PubMed ID: 10605344
    [No Abstract]   [Full Text] [Related]  

  • 12. [Objectives, indications and modalities of detoxification of the alcoholic patient].
    Soins; 2000 Apr; (644):suppl I-VI. PubMed ID: 11062672
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacology of disulfiram - an update].
    Mutschler J; Diehl A; Kiefer F
    Fortschr Neurol Psychiatr; 2008 Apr; 76(4):225-31. PubMed ID: 18415930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The lithium oxybutyrate correction of disorders in higher nervous activity in the progeny of alcoholized male rats].
    Nemova EP; Liubimov BI; Smol'nikova NM; Krylova AM; Trofimov SS
    Farmakol Toksikol; 1991; 54(1):65-7. PubMed ID: 1860506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy and mechanisms of action of lerivon in alcoholism].
    Ivanets NN; Anokhina IP; Kogan BM; Chirko VV; Nebarakova TP; Rusinov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(5):52-8. PubMed ID: 9012256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological basis of the screening of drugs for differentiated pharmacotherapy of alcoholism].
    Val'dman AV; Maĭskiĭ AI; Kampov-Polevoĭ AB; Treskov VG; Drozdov ES
    Vestn Akad Med Nauk SSSR; 1988; (3):28-32. PubMed ID: 3388968
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs for relapse prevention of alcoholism: ten years of progress.
    Spanagel R; Kiefer F
    Trends Pharmacol Sci; 2008 Mar; 29(3):109-15. PubMed ID: 18262663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate genes, pathways and mechanisms for alcoholism: an expanded convergent functional genomics approach.
    Rodd ZA; Bertsch BA; Strother WN; Le-Niculescu H; Balaraman Y; Hayden E; Jerome RE; Lumeng L; Nurnberger JI; Edenberg HJ; McBride WJ; Niculescu AB
    Pharmacogenomics J; 2007 Aug; 7(4):222-56. PubMed ID: 17033615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pathogenetic treatment of alcoholism].
    Seleznev AG
    Lik Sprava; 1997; (6):143-5. PubMed ID: 9589961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Software and hardware for computer equipment designed for psychophysiological examination].
    Matveev EV; Gal'etov IV; Vasil'ev AA; Kravchuk AIu; Tereshkina DV
    Med Tekh; 2005; (1):4-7. PubMed ID: 15757084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.